Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features
Christi A. Wilkins, Hannlie Hamman, Josias H. Hamman, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 178-178
Open Access | Times Cited: 18

Showing 18 citing articles:

Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Impact of disintegrants on rheological properties and printability in SSE 3D printing of immediate-release formulations
Morenikeji Aina, Darya Kuznyetsova, Fabien Baillon, et al.
European Journal of Pharmaceutical Sciences (2025) Vol. 206, pp. 107017-107017
Open Access | Times Cited: 1
Recent innovations in topical delivery for management of rheumatoid arthritis: A focus on combination drug delivery
Sriravali Karnam, Mahipal Reddy Donthi, Anil B. Jindal, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104071-104071
Closed Access | Times Cited: 6
New Ionic Liquid Forms of Antituberculosis Drug Combinations for Optimized Stability and Dissolution
Hanan E. Rasmy, Sara A. Abouelmagd, Hany S.M. Ali
AAPS PharmSciTech (2025) Vol. 26, Iss. 1
Open Access
Revolutionizing Fixed-Dose Combinations with Long-Acting Microsphere
Zhenhua Hu, Xiao Xiao, Guiyun Zhang, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107032-107032
Open Access
Targeted Oral Fixed-Dose Combination of Amphotericin B-Miltefosine for Visceral Leishmaniasis
Raquel Fernández-García, D. Walsh, P. O’Connell, et al.
Molecular Pharmaceutics (2025)
Closed Access
Flexipill: A Novel 3D Printed Personalised Analgesic Polypill with Diverse Targeted Drug Release Approaches.
Yasir Karkar, Ibrahim Amer, Amal Elkordy, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106882-106882
Closed Access
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
Luigino Calzetta, Clive P. Page, Maria Gabriella Matera, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1159-1220
Closed Access | Times Cited: 3
Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis
Nattanit Aekwattanaphol, Shyamal C. Das, Prakash Khadka, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124608-124608
Closed Access | Times Cited: 2
Engineered vildagliptin-loaded polymeric nanoparticles via microfluidic and spray drying for enhanced antidiabetic activity
Eknath Kole, Krishna Jadhav, Zia Ul Haq Khan, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
New insights from the integration of dapsone, flutamide, tea tree oil, and rose oil as a topical combined microemulsion for the management of Acne Vulgaris: Design, development, and in vitro/in vivo characterization.
Amgad E. Salem, Elham Abdelmonem Mohamed, Marwa Zohdy, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106276-106276
Closed Access | Times Cited: 1
Clinical Implications of Proton Pump Inhibitors and Vonoprazan Micro/Nano Drug Delivery Systems for Gastric Acid-Related Disorders and Imaging
Aseem Setia, Ranadheer Reddy Challa, Bhaskar Vallamkonda, et al.
Nanotheranostics (2024) Vol. 8, Iss. 4, pp. 535-560
Open Access | Times Cited: 1
A greener RP-HPLC method for quaternary estimation of caffeine, paracetamol, levocetirizine, and phenylephrine acquiring AQbD with stability studies
Vineetha Rosireddy, Manikandan Krishnan
Green Processing and Synthesis (2024) Vol. 13, Iss. 1
Open Access
Bosentan monohydrate and sildenafil base as two companions in enabling formulations
Dominik Strojewski, Sebastian Lalik, Florence Danède, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124312-124312
Open Access
Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases
András Inotai, Zoltán Kaló, Zsuzsanna Ida Petykó, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 186-186
Open Access
Relationship between Prices of Fixed-dose and Free-equivalent Combination: A Survey of Medicines in China's National Reimbursement Drug List
YIMAN FENG, Wei Li, Jiayun Wang, et al.
Research Square (Research Square) (2024)
Open Access
Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care
F.J. Alonso Moreno, J Espinosa García, F. López Simarro, et al.
Medicina de Familia SEMERGEN (2024) Vol. 51, Iss. 1, pp. 102337-102337
Closed Access
Analysis of fixed dose combinations and price variations of oral antidiabetic agents in the Indian pharmaceutical market
Angelina Geetha, Ramasamy Duraisamy, Yusuf Siddiq Jamal Ahamed, et al.
Indian Journal of Pharmacy and Pharmacology (2024) Vol. 11, Iss. 4, pp. 213-220
Open Access
Page 1

Scroll to top